Physician profile
April Lopez
NPI 1881023422
$416,782.20
in general payments reported to CMS, 2019-2025
9 companies · $984 in 2025
The $984 reported for 2025 was more than what 86% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $321 · 2022: $29K · 2023: $198 · 2024: $386K · 2025: $984.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Debt Forgiveness: $386K · Travel and Lodging: $721 · Food and Beverage: $513.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Debt Forgiveness | $386,100.00 |
| Travel and Lodging | $721.38 |
| Food and Beverage | $513.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Convatec INC. | $386,100.00 | 2024 | |
| Triad Life Sciences INC. | $28,800.00 | 2022 | |
| Medtronic, INC. | $951.91 | 2025 | Intellis Adaptivestim |
| Organogenesis INC. | $321.03 | 2021 | |
| Imbed Biosciences INC. | $198.44 | 2023 | |
| Astrazeneca Pharmaceuticals LP | $196.95 | 2022-2025 | Farxiga |
| Paratek Pharmaceuticals, INC. | $123.55 | 2022 | |
| Nuo Therapeutics | $68.50 | 2022 | |
| Orthofix Medical, INC. | $21.82 | 2024 | Cervical-Stim, Spinal-Stim |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw April Lopez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.